Mj. Ruckenstein et al., Effects of immunosuppression on the development of cochlear disease in theMRL-Fas(lpr) mouse, LARYNGOSCOP, 109(4), 1999, pp. 626-630
Objectives: The MRL-Fas(lpr) mouse, an animal that spontaneously develops m
ultisystemic autoimmune disease, has been proposed as model of immune-media
ted inner ear disease. Previous studies revealed that this mouse manifested
elevated auditory brainstem response thresholds, hydropic degeneration of
strial cells, and antibody deposition within strial capillaries, As the eti
ology of the observed strial disease may be immune, genetic, or uremic, a s
tudy was designed to attempt to delineate between these possible etiologic
factors, Study Design: Prospective, controlled animal study. Methods: Dexam
ethasone, which is known to suppress autoantibody production and glomerulon
ephritis in these animals, was administered systemically on a daily basis t
o experimental animals, beginning at 6 weeks of age, Control animals receiv
ed no treatment, Animals were allowed to age, with control animals predicta
bly manifesting systemic disease at 20 weeks of age, at which point all ani
mals were sacrificed, Results: Animals receiving dexamethasone treatment ma
nifested a significant reduction in serum immunoglobulin levels, lymphoid h
yperplasia, and a significant improvement in the level of renal function. H
owever, morphologic analysis revealed a persistence of strial disease despi
te the elimination of strial antibody deposition, Conclusion: The results o
f this experiment support the hypothesis that genetic mechanisms may be res
ponsible for the observed strial disease. Further studies are under way to
confirm these findings.